The 8 most recent market catalysts affecting $MASS, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.
Nov 13, 2026
Corporate Catalyst
Bullish
Impact 55
Canaccord Genuity Maintains Buy Rating and Raises Price Target for 908 Devices
Canaccord Genuity analyst Austin Moeller reiterated a 'Buy' rating for 908 Devices Inc. and raised the price target to $14.00 from $13.50. This action signals continued confidence …
Nov 10, 2026
Corporate Catalyst
Bullish
Impact 92
908 Devices Reports Third Quarter 2026 Financial Results
908 Devices (MASS) announced robust third-quarter 2026 financial results, showcasing a 35.4% increase in revenue to $18.95 million and a substantial reduction in net loss from $14.…
Sep 10, 2026
Corporate Catalyst
Neutral
Impact 55
Canaccord Genuity Initiates Coverage On 908 Devices with Buy Rating, Announces Price Target of $13.5
Canaccord Genuity's initiation of coverage on 908 Devices with a 'Buy' rating and a $13.5 price target signals a positive outlook from a reputable financial institution. This event…
Aug 12, 2026
Corporate Catalyst
Bullish
Impact 55
Stifel Maintains Buy on 908 Devices, Raises Price Target to $12
Stifel analyst Daniel Arias has maintained a 'Buy' rating on 908 Devices (MASS) and raised the price target from $10 to $12. This upgrade signals increased confidence from a promin…
Aug 12, 2026
Corporate Catalyst
Bullish
Impact 55
Roth Capital Maintains Buy on 908 Devices, Raises Price Target to $13
Roth Capital analyst Max Masucci maintained a 'Buy' rating on 908 Devices (MASS) and raised the price target from $11 to $13. This action signals continued confidence in the compan…
Aug 11, 2026
Corporate Catalyst
Bullish
Impact 85
908 Devices shares are trading higher after the company reported better-than-expected Q2 sales results and raised its FY26 sales guidance.
This headline represents a strong positive corporate catalyst for 908 Devices (MASS). Better-than-expected sales and raised guidance signal healthy demand for their products and ef…
Aug 11, 2026
Corporate Catalyst
Bullish
Impact 75
908 Devices Raises FY2026 Sales Guidance from $67.000M-$70.000M to $68.000M-$70.000M vs $68.585M Est
908 Devices (MASS) has updated its FY2026 sales guidance, raising the lower end of the range from $67.0 million to $68.0 million, while keeping the upper end at $70.0 million. This…
Jul 29, 2026
Corporate Catalyst
Neutral
Impact 55
Roth Capital Initiates Coverage On 908 Devices with Buy Rating, Announces Price Target of $11
Roth Capital's initiation of coverage on 908 Devices (MASS) with a 'Buy' rating and an $11 price target is a positive development for the company. Analyst coverage, especially with…
Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.